Applied DNA Sciences (NASDAQ: APDN) reported Q2 EPS of ($0.07), $0.05 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $1 million versus the consensus estimate of $900 thousand.

For earnings history and earnings-related data on Applied DNA Sciences (APDN) click here.